期刊文献+

GC法测定托吡司特中的水合肼残留量

Determination of the Residual Hydrazine Hydrate in Topiroxostat by GC
下载PDF
导出
摘要 建立一种气相色谱分析方法,测定托吡司特中的水合肼含量。采用DB-624毛细管色谱柱(30m×0.32mm,5μm);进样口温度为200℃;FID检测器,温度为250℃;升温程序:起始温度为95℃,保持5 min,再以10℃/min的速率升温至180℃,保持0 min,再以30℃/min的速率升温至225℃,保持4 min;载气为高纯氮气;进样量为1μL。结果显示二丙酮腙线性范围为0.00257~0.05135 mg·mL^(-1)(r=1.000);二丙酮腙平均回收率为101.4%,RSD为0.8%。该方法操作简便、快速准确,重复性好。 The gas chromatography(GC)method was established to determine residual hydrazine hydrate in topiroxostat.The determination was performed on DB-624 capillary column(30 m×0.32 mm,5μm)under the programmed temperature.FID was used,the inlet temperature was 200℃ and the detector temperature was 250℃.The high pure nitrogen was used as the carrier gas.The column temperature programmer was set as:remain the starting temperature of 95℃ for 5 min,increase to 180℃ at the rate of 10℃·min^(-1),then increase to 225℃ at the rate of 30℃·min^(-1) and remain 225℃ for 4 min.The injection volume was 1μL.The liner range of acetone azine was 0.00257~0.05135 mg·mL^(-1)(r=1.000).The average recovery rate of acetone azine(n=9)was 101.4%with its RSD value of 0.8%.The method is simple,fast and accurate,and has good repeatability.
作者 刘永波 Liu Yongbo(R&D center,Sinomune Pharmaceutical Co.,Ltd.,Wuxi 214194,China)
出处 《广东化工》 CAS 2021年第17期176-177,共2页 Guangdong Chemical Industry
关键词 GC 托吡司特 水合肼 GC topiroxostat hydrazine hydrate
  • 相关文献

参考文献3

二级参考文献37

  • 1International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline: Imurities in New Drug Substances Q3A(R2) [S/OL]. 2006-10. http://www.ich. org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q3A_R2/Step4/Q3A_R2__Guideline.pdf.
  • 2EMA (European Medicines Agency). Guidelines on the Limits of Genotoxic Impurities [S/OL]. 2006-06-28. http://www.EMA. europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002903.pdf.
  • 3European Directorate for the Quality of Medicines and Health Care. Enquiry: Alkyl mesilate (methane sulfonate) impurities in mesilate salts [J]. Pharm Europa, 2000, 12(1): 27.
  • 4Committee for Proprietary Medicinal Products. Position Paper on the Limits of Genotoxic Impurities [S]. 2002-12. CPMP/ SWP/5199/02/draft 2.
  • 5International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline: Impurities: Guideline for Residual Solvents Q3C(R) [S/OL]. 2005-11. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q3C/Step4/Q3C_R5_Step4.pdf.
  • 6Committee for Medicinal Products for Human Use (CHMP). Guidelines on the Limits of Genotoxic Impurities [S/OL]. 2006-06. http://www.ema.europa.eu/docs/en_GB/document_ library/Scientific_guideline/2009/09/WC500002903.pdf.
  • 7MUNRO I C, FORD R A, KENNEPOHL E, et al. Correlation of structural class with no observed effect levels: a proposal for establishing a threshold of concern [J]. Food Chem Toxicol, 1996, 34(9): 829- 867.
  • 8MUNRO I C. Safety assessment procedures for indirect food additives: an overview. Report of a workshop [J]. Regul Toxicol Pharmacol, 1990, 12(1): 2-12.
  • 9CHEESEMAN MA, MACHUGA E J, BAILEY A B. A tiered approach to threshold of regulation [J]. Food Chem Toxicol, 1999, 37(4): 387-412.
  • 10KROES R, RENWICK A G, CHEESEMAN M, et al. Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet [J]. Food Chem Toxicol, 2004, 42(1): 65-83.

共引文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部